Skip to main content

Advertisement

Table 1 Multivariate analysis of variance correlating CBX2 and clinicopathological features in primary PCa from MSKCC cohort

From: Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer

Factor F value p value Significance
Age 4.8235 0.030674 *
Extension 1.9261 0.131084  
Gleason 5.5086 0.021142 *
Nodal 15.4775 0.000165 ***
Race 0.7067 0.55053  
Sem Vesicle 0.0262 0.871665  
SurgMargins 0.0839 0.772712  
T stage 0.5005 0.607944  
  1. FDR false discovery rate
  2. ***p ≤ 0.001; *p ≤ 0.05